Skip to main content
. 2022 Aug 19;101(33):e26120. doi: 10.1097/MD.0000000000026120

Table 1.

Clinicopathological characters of the p16 positive and p16 negative HNSCC patients.

p16 positive HNSCC patients p16 negative HNSCC patients
Characteristics Subtype No. of cases (%) Characteristics Subtype No. of cases (%)
Age <60 18 (69.2) Age <60 35 (49.3)
≥60 8 (30.8) ≥60 36 (50.7)
Gender Male 23 (88.5) Gender Male 54 (76.1)
Female 3 (11.5) Female 17 (23.9)
Pathologic stage Stage I 1 (3.85) Pathologic stage Stage I 5 (7.0)
Stage II 3 (11.5) Stage II 5 (7.0)
Stage III 1 (3.85) Stage III 9 (12.7)
Stage IV 10 (38.5) Stage IV 44 (62.0)
NA 11 (42.3) NA 8 (11.3)
Pathologic T T1–T2 10 (38.5) Pathologic T T1–T2 20 (28.2)
T3–T4 7 (26.9) T3–T4 43 (60.5)
Tx 9 (34.6) Tx 8 (11.3)
Pathologic N N0 3 (11.5) Pathologic N N0 16 (22.5)
N1–N3 12 (46.2) N1–N3 48 (67.6)
Nx 11 (42.3) Nx 7 (9.9)
Vital status Alive 22 (84.6) Vital status Alive 46 (64.8)
Dead 4 (15.4) Dead 25 (35.2)

HNSCC = head and neck squamous cell carcinoma, NA, Nx, Tx = pathologic stage is unknown.